| Zeit | Aktuelle Nachrichten
| | Leser | Medien |
|---|
| 25.05.
| Vertex Announces Webcast of its Presentations at Two Investor Conferences | | 133 | Business Wire |
| Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that
Vertex will webcast its presentation at the Sanford C. Bernstein
Strategic Decisions Conference...
Mehr lesen zu:
Vertex Announces Webcast of its Presentations at Two Investor Conferences | |
| 25.05.
| Vertex Pharma Gets European CHMP Positive Opinion For KALYDECO | | 56 | AFX News |
| CAMBRIDGE (MASSACHUSETTS) (dpa-AFX) - Vertex Pharmaceuticals Inc. (VRTX)
announced that the European Committee for Medicinal Products for Human Use, or
CHMP, has issued a positive opinion...
Mehr lesen zu:
Vertex Pharma Gets European CHMP Positive Opinion For KALYDECO | |
| 25.05.
| Vertex erhält positive Stellungnahme des europäischen CHMP zu KALYDECO™ (Ivacaftor), dem ersten Medikament zur ursächlichen Behandlung der Mukoviszidose | | 52 | Business Wire |
| - Weltweit durchgeführte Studien zeigen signifikante und anhaltende
Verbesserungen der Lungenfunktion und anderer Krankheitsparameter bei
Patienten mit einer bestimmten...
Mehr lesen zu:
Vertex erhält positive Stellungnahme des europäischen CHMP zu KALYDECO™ (Ivacaftor), dem ersten Medikament zur ursächlichen Behandlung der Mukoviszidose | |
| 25.05.
| Vertex Pharmaceuticals (VRTX) Gets Positive Opinion from CHMP for KALYDECO | | - | StreetInsider.com |
| 25.05.
| Vertex Receives European CHMP Positive Opinion for KALYDECO™ (ivacaftor), the First Medicine to Treat the Underlying Cause of Cystic Fibrosis | | 37 | Business Wire |
| - Global studies showed significant and sustained improvements in
lung function and other measures of disease among people with a specific
genetic mutation -
...
Mehr lesen zu:
Vertex Receives European CHMP Positive Opinion for KALYDECO™ (ivacaftor), the First Medicine to Treat the Underlying Cause of Cystic Fibrosis | |
| 24.05.
| Vertex Pharmaceuticals Up 13.5% Since SmarTrend Uptrend Call | | 10 | SmarTrend |
| 24.05.
| Vertex Appoints David Altshuler, M.D., Ph.D., to its Board of Directors | | 41 | Business Wire |
| Vertex
Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that
David Altshuler, M.D., Ph.D., joined its board of directors as an
independent director....
Mehr lesen zu:
Vertex Appoints David Altshuler, M.D., Ph.D., to its Board of Directors | |
| 24.05.
| Perception, Opportunity in Volatility - Research & Analysis on Vertex Pharmaceuticals Incorporated and Huntington Bancshares Incorporated | | 24 | MarketWire |
| HONG KONG -- (Marketwire) -- 05/24/12 -- This morning, www.MarketFoundations.com announced new reports highlighting Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) and Huntington Bancshares Incorporated...
Mehr lesen zu:
Perception, Opportunity in Volatility - Research & Analysis on Vertex Pharmaceuticals Incorporated and Huntington Bancshares Incorporated | |
| 21.05.
| Vertex Pharmaceuticals: Spekulieren auf höhere Kurse? | | 234 | Börsenpoint |
| Investments in ein Unternehmen der Biobranche sind häufig mit besonderen Risiken verbunden und nicht selten stürzen die Kurse aus Unternehmen der Branche ins Bodenlose. Dass es aber auch anders gehen...
Mehr lesen zu:
Vertex Pharmaceuticals: Spekulieren auf höhere Kurse? | |
| 14.05.
| JP Morgan stuft Vertex Pharma von neutral auf overweight. | | 200 | BörseGo |
| JP Morgan stuft Vertex Pharma von neutral auf overweight.
(© BörseGo AG 2012 - Autor: Tobias Krieg, Redakteur)
Mehr lesen zu:
JP Morgan stuft Vertex Pharma von neutral auf overweight. | |
| 10.05.
| VERTEX - Endlich der Ausbruch! | | 263 | GodmodeTrader.de |
| 10.05.
| How High Can Vertex Pharmaceuticals Fly? | | 101 | Motley Fool |
| 09.05.
| Possible Bearish Inside Day Candle Pattern Detected for Vertex Pharmaceuticals | | 22 | SmarTrend |
| 09.05.
| Vertex Pharmaceuticals' shares soar, led by latest cystic fibrosis drug data | | 53 | China Post |
| 08.05.
| Vertex Pharma's CF Drug Outperforms | | 34 | Zacks |
| 08.05.
| Is Vertex Pharmaceuticals the Perfect Stock? | | 92 | Motley Fool |
| 08.05.
| Upgrade Alert for Vertex Pharmaceuticals | | 41 | SmarTrend |
| 08.05.
| Wells Fargo stuft Vertex Pharma von market perform auf outperform | | 190 | BörseGo |
| Wells Fargo stuft Vertex Pharma von market perform auf outperform
(© BörseGo AG 2012 - Autor: Tobias Krieg, Redakteur)
Mehr lesen zu:
Wells Fargo stuft Vertex Pharma von market perform auf outperform | |
| 08.05.
| Morgan Stanley stuft Vertex Pharma von underweight auf equal weight. | | 116 | BörseGo |
| Morgan Stanley stuft Vertex Pharma von underweight auf equal weight.
(© BörseGo AG 2012 - Autor: Tobias Krieg, Redakteur)
Mehr lesen zu:
Morgan Stanley stuft Vertex Pharma von underweight auf equal weight. | |
| 07.05.
| Vertex Pharmaceuticals Soars on Cystic Fibrosis Drug Study | | 57 | Minyanville |
